Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter StudyMarco Ruella, Liliana Devizzi, Andrea Riccardo Filippi et al.|International Journal of Radiation Oncology*Biology*Physics|2015Cited by 48
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological MalignanciesGiuseppe Messina, Benedetto Bruno, Giuseppe Console et al.|Biology of Blood and Marrow Transplantation|2012Cited by 30
Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?Francesca Giunta, G Bisi, Umberto Vitolo et al.|PubMed|2015Cited by 3